Article
BMC CANCER  (2009)

Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

Solares, Ana M; Santana, Agueda; Baladrón, Idania; Valenzuela, Carmen; González, Carlos A; Díaz, Alina; Castillo, Dagnelia; Ramos, Thelvia; Gómez, Roberto; Alonso, Daniel F; Herrera, Luis; Sigman, Hugo; Perea, Silvio E; Acevedo, Boris E; López-Saura, Pedro